Category: 2024

Femasys Receives CE Mark Approval for Four of its Women’s Health Products Clearing the Path for the Company to Begin Commercialization Efforts in Europe

EXCLUSIVE: Femasys At Inflection Point And Undervalued, Expects Growth Potential Following Roe v. Wade Overturn, CEO Says

‘Don’t Just Give Out the Work — Do the Work’: How This Women’s Healthcare CEO Leads With Passion

Indiana reports 98% drop in abortions after curbs

UPDATED: Industry hails Supreme Court’s decision to maintain mifepristone abortion pill’s access

Health Tech: Kathy Lee-Sepsick of Femasys On How Their Technology Can Make An Important Impact On Our Overall Wellness

Femasys founder Kathy Lee-Sepsick on entrepreneurship and the need for innovation in women’s health

Femasys CEO and Founder Kathy Lee-Sepsick Meets with the White House’s Office of Science and Technology Policy to Discuss the Cancer Moonshot Initiative

Femasys CEO and Founder Kathy Lee-Sepsick Meets with the White House’s Gender Policy Council

Femasys Is Putting Women in Charge of Their Reproductive Health